MACM
March Altus Capital Management Portfolio holdings
AUM
$16M
1-Year Return
18.92%
This Quarter Return
-8.76%
1 Year Return
+18.92%
3 Year Return
+153.93%
5 Year Return
–
10 Year Return
–
AUM
$17M
AUM Growth
-$224K
(-1.3%)
Cap. Flow
+$720K
Cap. Flow
% of AUM
4.24%
Top 10 Holdings %
Top 10 Hldgs %
86.05%
Holding
28
New
8
Increased
3
Reduced
3
Closed
14
Top Buys
| 1 |
Edwards Lifesciences
EW
|
$4.84M |
| 2 |
Gilead Sciences
GILD
|
$1.69M |
| 3 |
Acadia Pharmaceuticals
ACAD
|
$1.62M |
| 4 |
PETX
Aratana Therapeutics, Inc.
PETX
|
$935K |
| 5 |
MDCO
Medicines Co
MDCO
|
$838K |
Top Sells
| 1 |
Universal Health Services
UHS
|
$2.08M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$1.08M |
| 3 |
THOR
THORATEC CORPORATION
THOR
|
$1.05M |
| 4 |
United Therapeutics
UTHR
|
$985K |
| 5 |
CYNO
Cynosure, Inc. Class A
CYNO
|
$983K |
Sector Composition
| 1 | Healthcare | 81.62% |